Clinical Trials Logo

Clinical Trial Summary

The study objectives are to evaluate Tonsitin™ (10% Lactic Acid) safety, tolerability and preliminary efficacy, as a potent treatment for Recurrent Tonsillitis in children.


Clinical Trial Description

n/a


Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator), Primary Purpose: Treatment


Related Conditions & MeSH terms


NCT number NCT01988558
Study type Interventional
Source Yali Pharmaceuticals
Contact
Status Completed
Phase Phase 1/Phase 2
Start date December 2013
Completion date September 2016